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HIGHLIGHTS 
 A potential anti-inflammatory peptide was purified from lupine protein 
hydrolysate 
 The sequence was Gly-Pro-Glu-Thr-Ala-Phe-Leu-Arg
 This octapeptide may help to prevent diseases related to chronic inflammation 
*Highlights
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
1 
GPETAFLR: A NEW ANTI-INFLAMMATORY PEPTIDE FROM Lupinus 
angustifolius L. PROTEIN HYDROLYSATE 
Mª del Carmen Millán-Linares, Francisco Millán, Justo Pedroche, María del Mar Yust * 
Instituto de la Grasa (CSIC), Carretera Utrera km 1, 41013 Sevilla, Spain 
 *Corresponding author: 
María del Mar Yust 
Departamento de Alimentación y Salud, Instituto de la Grasa (CSIC) 
Carretera Utrera km 1 
Campus Universidad Pablo de Olavide 
41013-Sevilla, Spain 
E-mail: mdmar@cica.es 
Phone number: +34 954611550 
*Manuscript
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
Abstract  
An anti-inflammatory peptide was identified in lupine protein hydrolysate (LPH) 
obtained by enzymatic hydrolysis of lupine protein isolate (LPI) with Alcalase. LPH 
was separated in two fractions by ultrafiltration, and anti-inflammatory activity was 
evaluated by analysis of the expression of different cytokines in THP-1-derived 
macrophages by quantitative PCR (qPCR). Fraction <10 kDa was purified by 
chromatographic techniques, and the most active subfraction was analysed by mass 
spectrometry. A novel anti-inflammatory peptide was identified and the sequence was 
Gly-Pro-Glu-Thr-Ala-Phe-Leu-Arg. This peptide was synthesised, and its anti-
inflammatory activity was tested at two concentrations. Expression of TNF, IL-1β, and 
CCL2 was significantly reduced whereas the expression of the anti-inflammatory 
cytokine IL-10 was induced. Regarding the production of cytokines, only the lowest 
concentration of the synthetic peptide showed anti-inflammatory properties. 
Furthermore, the synthetic peptide decreased nitric oxide production. Thus, the 
identified peptide may help to prevent chronic inflammation associated with several 
diseases. 
Keywords
Lupine protein hydrolysates, anti-inflammatory activity, THP-1-derived macrophages, 
purification, octapeptide. 
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1. Introduction 
Proteins are an essential source of energy and amino acids. In addition to nutritional 
value, dietary proteins serve many functions in vivo by means of biologically active 
peptides (Sharma, Singh, & Rana, 2011). Bioactive peptides are small amino acid 
sequences that are inactive in the native protein but can be released by digestive 
enzymes during gastrointestinal transit, by fermentation or ripening during food 
processing, and by proteolysis by enzymes derived from microorganisms, plants, or 
animals. Until now, milk proteins have been considered as the most important source of 
bioactive peptides (Korhonen, 2009). Plant proteins are less expensive and therefore a 
valuable alternative for the production of bioactive peptides derived from dietary 
protein (Aluko, 2008). Legumes and cereals are the main source of plant proteins in the 
human diet. Among legumes, soybean and lupine stand out for their protein content (35-
40%) from others such as pea or chickpea that do not exceed 30% (Day, 2013). Various 
biological activities have been attributed to lupine proteins, but hypocholesterolaemic 
and antioxidant activities have been studied the most extensively to date (Yoshie-Stark 
& Wäsche, 2004; Osman, Mahmoud, Romeilah & Fayed, 2011).  
Inflammation is an important normal immune response during lesions and infections. 
However, excessive inflammation can contribute to several acute and chronic diseases 
characterised by the uncontrolled production of pro-inflammatory cytokines, 
eicosanoids derived from arachidonic acid, reactive oxygen species and adhesion 
molecules (Calder, 2006). Inhibitors of pro-inflammatory cytokines have therefore been 
considered as candidates of anti-inflammatory drugs. Chronic inflammation is a 
hallmark of several pathologies, such as rheumatoid arthritis, inflammatory bowel 
disease, atherosclerosis and cancer. The increase in the incidence of inflammation-
related disorders has led to a search for proteins and peptides with anti-inflammatory 
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properties (Mao, Cheng, Wang, & Wu, 2011; Ndiaye, Vuong, Duarte, Aluko, & Matar, 
2012). Although different plant protein hydrolysates have shown anti-inflammatory 
properties (Oseguera-Toledo, Gonzalez de Mejia, Dia, & Amaya-Llano, 2011; Ndiaye 
et al., 2012; McCarthy, O’Callaghan, Connolly, Piggott, FitzGerald, & O’Brien, 2013), 
few specific peptides have been isolated from them. The most studied plant anti-
inflammatory peptide is lunasin, a 43-amino acid chemopreventive peptide which has 
been isolated from soybean, barley, wheat, rye and triticale (Dinelli et al., 2014). It has 
been reported that lunasin from soybean inhibits inflammation in LPS-induced RAW 
264.7 macrophage by suppressing NK-κΒ pathway (Gonzalez de Mejia, & Dia, 2009). 
We have previously shown that lupine protein hydrolysates (LPHs) present potential 
anti-inflammatory activity by the inhibition of enzymes involved in the inflammation 
pathway (Millán-Linares, Yust, Alcaide-Hidalgo, Millán, & Pedroche, 2014) and the 
reduction of pro-inflammatory cytokine expression in THP-1-derived macrophages 
(Millán-Linares, Bermúdez, Yust, Millán, & Pedroche, 2014). The aim of this work was 
to detect the peptide or peptides responsible for the anti-inflammatory activity of LPHs. 
An octapeptide was identified and it was synthesised, and the anti-inflammatory activity 
was evaluated by measuring the expression and production of the pro-inflammatory 
cytokines TNF, IL-1β, IL-6, C-C chemokine receptor type 2 (CCR2), chemokine (C-C 
motif) ligand 2 (CCL2), and the anti-inflammatory cytokines chemokine (C-C motif) 
ligand 18 (CCL18), and IL10. Moreover, the effect of the peptide on nitric oxide 
production was also evaluated. 
2. Materials and methods 
2.1 Materials 
Seeds of lupine (L. angustifolius L.) were a gift from Koipesol Semillas, S.A. (Sevilla, 
Spain). Alcalase 2.4 L was provided by Novozymes (Bagsvaerd, Denmark). Cells were 
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THP-1 monocytes ATCC® Number TIB-202TM, and the medium used for this line was 
Gibco® RPMI 1640 (Life Technologies SA, Alcobendas-Madrid, Spain). Phosphate 
buffered saline (PBS), foetal bovine serum (FBS), and penicillin/streptomycin solution 
(P/S) were also obtained from Gibco®. Dimethyl sulphoxide (DMSO), phorbol 12-
myristate 13-acetate (PMA), and trypan blue solution were purchased from Sigma 
Chemical Co. (St. Louis, MO, USA). An iScript cDNA synthesis kit was from Bio-Rad 
Laboratories (Hercules, CA, USA). Brilliant II Syber® Green qPCR Master Mix was 
purchased from Agilent Technologies (Santa Clara, CA, USA). Primers were purchased 
from Eurofins Biolab S.L.U (Barcelona, Spain). NucleoSpin RNA II was from 
Macherey-Nagel GmbH & Co. KG (Düren, Germany). The ultrafiltration membrane 
with a molecular weight cut-off (MWCO) of 10 kDa was from Millipore Corporation 
(Billerica, MA, USA). Acetonitrile (ACN) and trifluoroacetic acid (TFA) were from the 
Merck Group (Darmstadt, Germany). ELISA kits for TNF, IL-1β and IL-10 were from 
Bionova Scientific (Madrid, Spain). 
2.2 Obtaining the lupine protein isolate 
Lupine protein isolate (LPI) was obtained through the method of Yust, Pedroche, 
Millán-Linares, Alcaide-Hidalgo, & Millán, F (2010) at pilot plant scale (Plant Proteins 
Group, Instituto de la Grasa). The chemical composition of LPI in dry matter was: 
Proteins 86.83%; dietary fibre 5.97%; oil 5.08%; ash 0.78%, carbohydrates 1.34%. 
2.3 Preparation of the lupine protein hydrolysate 
Hydrolysis was carried out according to Millán-Linares et al., 2014b. LPI was 
suspended in distilled water (10% w/v), and hydrolysis with Alcalase was performed 
under the following conditions: pH 8, 50º C, E/S= 0.3 AU/g protein, and a hydrolysis 
time of 15 min. The mixture was heating at 85º C for 15 min to inactivate the enzyme, 
centrifuged at 6500 g for 15 min, and the supernatant constituted the LPH. 
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2.4 Purification of the anti-inflammatory peptide 
2.4.1 Fractionation of lupine protein hydrolysates by ultrafiltration 
LPH was fractionated through an ultrafiltration membrane with a molecular weight cut-
off of 10 kDa. Two fractions were recovered, lyophilised, and named MW1 (retentate, 
molecular weight >10 kDa) and MW2 (permeate, molecular weight <10 kDa). 
2.4.2 Purification of anti-inflammatory peptides by reversed-phase chromatography 
The fraction exhibiting the highest anti-inflammatory activity after ultrafiltration was 
further purified on a Resource RPC 3 mL column (GE Healthcare, Uppsala, Sweden). 
The injection volume was 0.5 mL, and the sample concentration was 30 mg/mL. The 
mobile phase consisted of two solutions: solvent A (0.065% TFA, 2% acetonitrile 
(ACN)) and solvent B (0.050 TFA, 80% ACN). Elution was achieved by the following 
gradient program: 0-25.73 mL, elution with 100% solvent A; 25.73-90.07 mL, linear 
gradient from 100% A to A:B 20:80. The eluted peptides were detected at 280 nm. 
Seventeen fractions (F1-F17) were collected, dried under a nitrogen stream to remove 
ACN and TFA, and lyophilised. 
2.4.3 Purification of anti-inflammatory peptides by gel filtration chromatography. 
The most active fraction obtained from reversed-phase chromatography was further 
purified on a SuperdexTM peptide 10/300 GL column (GE Healthcare). The injection 
volume was 0.5 mL, and the sample concentration was 10 mg/mL. The buffer used as 
eluent was 2% ACN and 0.065% TFA at a flow rate of 1.0 mL/min. Elution was 
monitored at 214 nm, and five fractions (F3-1 to F3-5) were collected, dried under a 
nitrogen stream, and lyophilised. 
2.5 Amino acid sequence identification 
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The sequence of the purified peptide was identified through sequence analysis by 
nanoHPLC coupled to a Polaris Q ion-trap mass spectrometer (Mass Spectrometry Unit, 
Instituto de la Grasa, Sevilla, Spain). 
2.6 Cell culture and treatments 
The human monocytic THP-1 cell line in suspension was cultured at 37º C and 5% CO2 
in RPMI medium 1640 supplemented with 1% P/S and 10% heat-inactivated FBS. 
Monocytes were differentiated and polarised to classically activated M1 macrophages 
by incubation with PMA (100 nmol/L) for 4 days. PMA-stimulated THP-1 cells 
(referred to as THP-1–derived macrophages) were exposed to RPMI medium 
(supplemented with 1% FBS) for 24 h and then treated with the samples at a 
concentration of 500 μg/mL RPMI medium (1% FBS) for 6 h. In the case of the 
synthetic peptide two concentrations (100 and 500 μg/mL) and two incubation times (6 
and 48 h) were tested. Control without sample was only composed of RPMI medium 
(1% FBS). 
2.7 Cell viability 
The reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to 
formazan was used to asses possible cytotoxic effect on THP-1-derived macrophages. 
2.8 mRNA extraction and analysis of PCR products 
Total RNA was extracted from THP-1-derived macrophages using NucleoSpin® RNA 
II. RNA quality was assessed by the OD260:OD280 ratio in a NanoDrop ND-1000 
Spectrophotometer (Thermo Scientific, Waltham, MA, USA). One microgram of total 
RNA was subjected to RT-PCR to obtain cDNA according to the manufacturers’
protocol. 
The mRNA levels for specific genes were determined on an Mx3000P system 
(Stratagene, La Jolla, CA, USA). All reactions were performed in triplicate in a total 
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volume of 25 µL containing 12.5 µL of Brilliant II SYBR green qPCR master mix, 2.5 
µL of upstream primer (300 nM final concentration) and 2.5 µL of downstream primer 
(300 nM final concentration), 5 µL of diethylpyrocarbonate-treated water and 2 µL of 
template cDNA (10 ng). The reference genes HPRT and GAPDH were used to correct 
for RNA concentration differences between the samples. 
The thermal cycling conditions were as follows: 95º C for 10 min, 40 cycles of 95º C 
for 30 s, 56º C for 1 min and 72º C for 30 s. 
The magnitude of the change in mRNA expression for candidate genes was calculated 
using the standard 2–(ΔΔCt) method. All data were normalised to endogenous reference 
(HPRT and GAPDH) gene levels and expressed as percentages of the control. 
2.8 Enzyme-linked immunosorbent assay (ELISA). 
TNF, IL-1β and IL10 concentrations in cell culture supernatants were quantified using 
commercial ELISA kits according to the manufacturer’s instructions. 
2.9 Synthesis of the peptide 
The peptide was synthesised by Fmoc solid-phase method by the Barcelona Scientific 
Park Foundation (Barcelona, Spain) at 95% purity, measured by HPLC-UV at 220 nm. 
2.10 Measurements of nitrite in THP-1-derived macrophages cells.  
As an indicator of NO production, nitrite (NO2-) concentration was measured in the cell 
culture supernatants. Equal volumes of culture supernatants and Griess reagent were 
mixed and the absorbance was read at 540 nm in the microplate reader (Green, Wagner, 
Glogowski, Skipper, Wishnok, & Tannenbaum, 1981). The amount of nitrite was 
obtained by an extrapolation from a standard curve with sodium nitrite. 
2.10 Statistical analysis 
Data are presented as the mean ± SEM of three independent determinations. Group-wise 
statistical comparisons were performed by one-way ANOVA with a post hoc Holm-
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Bonferroni test. Differences were considered to be significant at P <0.05. 
3. Results and discussion
3.1 Purification of anti-inflammatory peptides from LPH
We previously demonstrated that LPHs obtained using commercial proteases inhibited 
the activity of some of the enzymes involved in the inflammatory pathway, such as 
phospholipase A2, cyclooxygenase-2, transglutaminase and thrombin (Millán-Linares et 
al., 2014b). These results were subsequently confirmed by the reduction of cytokine 
expression in THP-1-derived macrophages, and this was the first report to describe the 
anti-inflammatory effect in these cells and influence the control of macrophage 
polarisation in the context of an inflammatory state (Millán-Linares et al., 2014a). 
We concluded that LPH, obtained by the enzymatic hydrolysis of lupine protein isolate 
with Alcalase, is a good raw material for the purification and identification of anti-
inflammatory peptides from lupine. 
3.1.1 Purification of peptides by ultrafiltration 
Ultrafiltration processes are used to purify bioactive peptides from protein hydrolysates 
(Majumder & Wu, 2011; Vo, Ryu & Kim, 2013). The LPH produced after hydrolysis 
with Alcalase 2.4 L (as described in 2.3) was used as the substrate for the purification of 
anti-inflammatory peptides by ultrafiltration with a membrane with a molecular weight 
cut-off of 10 kDa, and two fractions were obtained: retentate with a molecular weight 
>10 kDa (MW1) and permeate with a molecular weight <10 kDa (MW2) representing, 
respectively, 15.72 and 84.28% of the mass recovered after the ultrafiltration process. 
The effect of these two fractions on the expression of TNF, IL-1β, IL-6, CCR2, CCL2 
(pro-inflammatory cytokines) and CCL18 (anti-inflammatory cytokine) was evaluated 
by qPCR relative to a control without treatment (Figure 1). Expression of TNF (Figure 
1A) and CCL2 (Figure 1E) was significantly reduced by the two fractions obtained by 
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ultrafiltration. So, MW1 induced the down-regulation of TNF and CCL2 in activated 
macrophages by 41 and 32%, respectively, whereas MW2 reduced by 50% the 
expression of these two cytokines. Expression of the other pro-inflammatory cytokines, 
except CCR2, was also repressed, although significant differences were not observed. 
Both fractions seemed to induce CCL18 expression, but this up-regulated expression 
was not significant (Figure 1F). Considering these results, the higher mass recovery, and 
the fact that peptides with a relatively low molecular weight seem to show a higher 
intestinal absorption and bioavailability (Roberts, Burney, Negro, & Zaloga, 1999), 
MW2 (< 10 kDa) was chosen for the next purification step. 
3.1.2 Purification of MW2 by reversed-phase chromatography 
MW2 was used for further purification of anti-inflammatory peptides by reversed-phase 
chromatography (Seber et al., 2012). Seventeen fractions (F1-F17) were collected, and 
the percentage of mass recovery with respect to the total mass was 7.13, 1.89, 10.04, 
15.42, 16.45, 10.04, 5.38, 2.47, 4.80, 6.98, 2.76, 6.11, 2.33, 2.33, 1.60, 1.75 and 2.32, 
respectively. Fractions F1-F5 corresponded to unbound peptides and constituted almost 
51% of the total mass. Fractions F6-F17 were composed of peptides with increasing 
hydrophobicity and represented 49% of the total mass. The potential anti-inflammatory 
activity of all these fractions were tested by measuring the expression of TNF and IL-1β
by qPCR, and was “yes” (Y) when the fractions down-regulated cytokine expression 
and “no” (N) when the fractions did not down-regulate cytokine expression (Figure 2). 
Only F3 and F7 reduced the gene expression of both cytokines. The expression of 
cytokines IL-6, CCR2, CCL2 and CCL18 was then evaluated to verify which of the two 
fractions may have greater anti-inflammatory potential. Expression of CCR2, which had 
not been reduced by the ultrafiltration fractions, and CCL2 was strongly repressed by 
both fractions (Figures 3B and 3C). In fact, F3 reduced the expression of CCR2 and 
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CCL2 by 55 and 39%, and F7 induced the down-regulation of both cytokines at more 
than 70%. Moreover, IL-6 expression was significantly reduced with respect to the 
control by F3 and F7 (-52 and -66%, respectively) (Figure 3A), and the expression of 
CCL18 was up-regulated (Figure 3D) by the two fractions above 100%. Ultimately, F3 
was selected for further purification because it had a recovery rate nearly twice that of 
the F7 fraction. 
3.1.3 Purification of F3 by gel filtration chromatography 
Gel filtration chromatography has been used in numerous studies for the purification 
and identification of bioactive peptides from the protein hydrolysates of several sources, 
such as soybeans (Kim, Bae, Ahn, Lee, & Lee, 2007). F3 was loaded onto a Superdex 
peptide column, and the eluate was divided into five fractions named F3-1, F3-2, F3-3, 
F3-4, and F3-5 (Figure 4), and the weight yield of each fraction was 23.67, 18.70, 
27.20, 8.89 and 21.45%. The expression of TNF and IL-1β was evaluated by qPCR and 
was “yes” (Y) when the fractions down-regulated cytokine expression and “no” (N) 
when the fractions did not down-regulate cytokine expression (Figure 4). Only F3-5 
down-regulated TNF expression, and thus, this fraction was selected for the rest of the 
analyses. Although no significant differences were observed in IL-6 expression (Figure 
5A), F3-5 dramatically reduced CCR2 and CCL2 expression, -59.54% and -74.45%, 
respectively (Figures 5B and 5C). These results indicate that F3-5 tends to decrease the 
pro-inflammatory capacity of activated M1 macrophages by diminishing the expression 
of cytokines involved in pro-inflammatory processes. Regarding anti-inflammatory 
cytokines, CCL18 and IL-10 (Figures 5D and 5E) levels were significantly up-regulated 
by the same fraction, and this up-regulation was higher for IL-10 (184% vs 53% for 
CCL18), an anti-inflammatory cytokine with a crucial role in preventing inflammatory 
and autoimmune pathologies (Moore, de Waal Malefyt, Coffman, & O'Garra, 2011). 
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F3-5 was then analysed by mass spectrometry, and a major peptide of 889.6 Da whose 
sequence was Gly-Pro-Glu-Thr-Ala-Phe-Leu-Arg was identified. According to 
literature, anti-inflammatory peptides possess a wide range of molecular weight. Thus, 
anti-inflammatory peptide with 5 kDa (lunasin), 8 and 14 kDa (lunasin-like peptide) and 
377.47 Da (VPY) molecular weight have been purified from soybean (Dia, Wang, Oh, 
de Lumen, & Gonzalez de Mejia, 2009; Kovacs-Nolan et al., 2012). Anti-inflammatory 
peptides in the range 1-5 kDa have been detected in casein hydrolysates (Mukhopadhya 
et al., 2014), and anti-inflammatory peptides with molecular weight lower than 1 kDa 
have been isolated from microalgae and aquatic organisms (Lee et al., 2012; Vo et al., 
2013; Ahn, Cho, & Je, 2015). 
Due to the low number of sequenced anti-inflammatory peptides, it was not possible 
establish a correlation between the anti-inflammatory activity and any amino acid. As in 
the case of lunasin, it is probably that the sequence we have identified could be present 
in other plant proteins. 
The peptide was synthesised for further studies in the determination and expression of 
cytokines by qPCR and ELISA. 
3.2 Anti-inflammatory activity of the synthetic peptide 
THP-1-derived macrophages were treated with the synthetic peptide at two different 
concentrations: 100 µg/mL (P1) and 500 µg/mL (P2). Viability of cells treated with the 
peptide was not significantly reduced at peptide concentrations ranging 100-2000 
µg/mL. 
3.2.1 Measurement of cytokine expression by qPCR 
The expression of TNF (Figure 6A) and IL-1β (Figure 6B) was significantly suppressed 
compared to the control by 40%, and significant differences were not observed between 
the different concentrations. Neither P1 nor P2 significantly modified the IL-6 gene 
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expression (Figure 6C). Furthermore, the synthetic peptide significantly reduced CCL2 
expression at both concentrations by 50% (Figure 6D). The receptor CCR2 only showed 
significant differences compared to the control after treatment at concentration P1 
(Figure 6E). 
Regarding the expression of anti-inflammatory cytokines, only IL-10 was induced by 
the synthetic peptide at both concentrations (Figure 7B). These results are slightly 
different with respect to the purified fraction F3-5 because CCL18 expression obtained 
by qPCR was higher than the control and the synthetic peptide did not up-regulate 
CCL18 expression at any of the concentrations used (Figure 7A). These small 
differences in the expression of pro- and anti-inflammatory cytokines between F3-5 
(obtained from LPH after purification by ultrafiltration and chromatography) and the 
synthetic peptide could be due to the interaction of cells with any minor differences in 
amino acid sequence from the synthetic peptide. 
3.2.2 Determination of cytokine production by ELISA 
The concentration of TNF, IL-1β and IL-10 was determined in the supernatants of cell 
cultures after treatment with the synthetic peptide at concentrations P1 and P2 for 6 and 
48 h to observe possible fluctuations in protein levels. The production of TNF and IL-1β 
decreased significantly (-42 and -39%, respectively) compared to the control after 6 h of 
treatment with the peptide at 100 µg/mL, whereas P2 did not result in any significant 
differences with respect to the control (Figures 8A1 and 8B1, respectively). However, 
the decrease in TNF and IL-1β due to P1 was not observed in the supernatant of the cell 
culture after 48 h (Figures 8A2 and 8B2). In contrast, the production of IL-10 only 
increased after 48 h (Figure 8C2) and was significantly different from the control in P1. 
The lowest dose of the peptide, P1 (100 µg/mL), acted both at the transcriptional and 
posttranscriptional levels, exerting an anti-inflammatory effect in the short term (6 h) by 
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inhibiting TNF and IL-1β secretion and in the long-term (48 h) by inducing the 
secretion of the anti-inflammatory cytokine IL-10. 
3.2.3 Effect of the synthetic peptide on nitrite production 
Nitric oxide has been shown to play a central role in inflammatory and immune reaction 
activities and macrophages appear to be the main cellular source of NO (Montserrat-de 
la Paz, Fernández-Arche, Ángel-Martín & García-Giménez, 2012). The effect of the 
synthetic peptide on the release of this inflammatory mediator is depicted in Figure 9. 
Both concentrations inhibited the NO production; although the highest concentration of 
peptide seemed to show highest inhibition, there was no statistical difference between 
P1 and P2. Similar results were obtained by Ahn et al (2015), who reported that the 
treatment with peptide PAY (purified from salmon byproduct hydrolysates) at 0.25 mM 
(≈0.1 mg/mL) reduced by 57% the NO production in LPS-stimulated RAW264.7 
macrophages. These authors described that the inhibition was in a dose dependent 
manner, although there was not statistical difference at concentrations higher than 0.5 
mM. 
In conclusion, an anti-inflammatory octapeptide was purified from a L. angustifolius
protein hydrolysate by ultrafiltration and reversed-phase and gel filtration 
chromatographies. The sequence was identified as Gly-Pro-Glu-Thr-Ala-Phe-Leu-Arg, 
and the peptide was synthesised. Anti-inflammatory activity of the synthetic peptide 
was corroborated by studying the expression of cytokines by qPCR, the levels of these 
proteins by ELISA, and the inhibition of NO production in THP-1-derived 
macrophages. To the best of our knowledge, this is the first report of an anti-
inflammatory peptide purified from a L. angustifolius protein hydrolysate. Further 
investigations on in vivo studies of these activities would be necessary to establish 
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strategies for specific pathophysiological conditions that could mark the possible use of 
these compounds in specialised nutrition. 
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Figure captions 
Figure 1. TNF (A), IL-1β (B), IL-6 (C), CCR2 (D), CCL2 (E), and CCL18 (F) mRNA 
expression in THP-1-derived macrophages after 6 h of treatment with MW1 (˃10 kDa) 
and MW2 (˂10 kDa) at 0.5 mg/mL. Values marked with different letters are 
significantly different (P<0.05). 
Figure 2. Reversed-phase chromatography of MW2 (<10 kDa). Seventeen fractions 
were collected, and the reduction of TNF and IL-1β mRNA expression was measured in 
THP-1-derived macrophages after 6 h of treatment with each fraction at 0.5 mg/mL. 
“Yes” (Y) values reflect the down-regulation of cytokine expression by the fractions, 
and “no” (N) values indicate that cytokine expression was not down-regulated. 
Figure 3. IL-6 (A), CCR2 (B), CCL2 (C), and CCL18 (D) mRNA expression in THP-1-
derived macrophages after 6 h of treatment with F3 and F7 obtained from reversed-
phase chromatography (RPC column, 3 mL) at 0.5 mg/mL. Values marked with 
different letters are significantly different (P<0.05). 
Figure 4. Elution profile of F3 from RPC on a Superdex peptide 10/300 gel filtration 
column. Five fractions were collected, and the reduction of TNF and IL-1β mRNA 
expression was measured in THP-1-derived macrophages after 6 h of treatment with 
each fraction at 0.5 mg/mL. “Yes” (Y) values reflect the down-regulation of cytokine 
expression by the fractions, and “no” (N) values indicate that cytokine expression was 
not down-regulated. 
Figure 5. IL-6 (A), CCR2 (B), CCL2 (C), CCL18 (D), and IL-10 (E) mRNA expression 
in THP-1-derived macrophages after 6 h of treatment with F3-5 obtained from gel 
filtration chromatography at 0.5 mg/mL. Values marked with different letters are 
significantly different (P<0.05). 
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Figure 6. TN
F (A
), IL-1β (B), IL-6 (C), CC
L2 (D
), and CCR2 (E) m
RN
A
 expression in 
TH
P-1-derived m
acrophages after 6 h of treatm
ent w
ith the synthetic peptide at 100 
µg/m
L (P1) and 500 µg/ m
L (P2). V
alues m
arked w
ith different letters are significantly 
different (P<0.05). 
Figure 7. CC
L18 (A
) and IL-10 (B) m
RN
A
 expression in TH
P-1-derived m
acrophages 
after 6 h of treatm
ent w
ith the peptide synthesised at 100 µg/m
L (P1) and 500 µg/m
L 
(P2). V
alues m
arked w
ith different letters are significantly different (P<0.05). 
Figure 8. Effect on TN
F (A
), IL-1β (B), and IL-10 (C) production of TH
P-1-derived 
m
acrophages after 6 h (1) and 48 h (2) of treatm
ent w
ith a peptide concentration of 100 
µg/m
L (P1) and 500 µg/m
L (P2). V
alues m
arked w
ith different letters are significantly 
different (P < 0.05). 
Figure 9. N
O
 production (%
) in TH
P-1-derived m
acrophages after 48 h of treatm
ent 
w
ith a peptide concentration of 100 µg/m
L (P1) and 500 µg/m
L (P2). V
alues m
arked 
w
ith different letters are significantly different (P < 0.05). 
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Table S1. Oligonucleotide sequences of forward and reverse primers used in qPCR. 
Gene Accession number Forward primer (5´-3´) Reverse primer (5´-3´)
TNF NM_000594.3 TCCTTCAGACACCCTCAACC AGGCCCCAGTTTGAATTCTT
IL-1β NM_138712 GCTGTGCAGGAGATCACAGA GGGCTCCATAAAGTCACCAA
IL-6 NM_001001928 GTTTGAGGGGGTAACAGCAA GCTAACTGCAGAGGGTGAGG
CCR2 NM_001002 TCGACAATGGCAGCATCTAC ATCCGTCTCCACAGACAAGG
CCL2 NM_002982.3 CCCCAGTCACCTGCTGTTAT TGGAATCCTGAACCCACTTC
CCL18 NM_002957 GGGTTTTCTTCCCTTTCGAG GCGTGTTCCTTTTCCACAAT
IL-10 NM_000572.2 GTTCTTTGGGGAGCCAACAG GCTCCCTGGTTTCTCTTCCT
HPRT NM_000194.2 ACCCCACGAAGTGTTGGATA AAGCAGATGGCCACAGAACT
GAPDH NM_002046.4 GAGTCAACGGATTTGGTCGT TTGATTTTGGAGGGATCTCG
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